The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

Find Cheap Health Insurance Quotes in Your Area Weight loss drugs cost an average of $1,083 per month or $12,996 per year if you pay full price without any discounts or coupons. If your insurance ...

The Biden administration unveiled its list of 15 drugs, which include GLP-1 drugs, for the second annual round of drug price ...

When such discounts and rebates are factored in ... been scrutinized over the pricing of its blockbuster diabetes drug Ozempic and weight loss drug Wegovy. The company's top executive was ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

GLP-1 drugs such as Ozempic, Wegovy and Zepbound are growing in popularity ... States — ranging from about $940 to $1,350 a month before insurance, rebates or discounts — many patients can’t afford ...